Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012–2024)
- DOI
- 10.1016/j.lana.2026.101621
- Published
- 2026-11
- Container
- The Lancet Regional Health - Americas
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.lana.2026.101621,
title = {Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012–2024)},
author = {Daniel da Silva Pereira Curado and Marisa Santos and Alfredo Palacios and Ivan Ricardo Zimmermann and Everton Nunes da Silva},
year = {2026},
journal = {The Lancet Regional Health - Americas},
doi = {10.1016/j.lana.2026.101621},
url = {https://doi.org/10.1016/j.lana.2026.101621}
}RIS
TY - JOUR TI - Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012–2024) AU - Daniel da Silva Pereira Curado AU - Marisa Santos AU - Alfredo Palacios AU - Ivan Ricardo Zimmermann AU - Everton Nunes da Silva PY - 2026 JO - The Lancet Regional Health - Americas DO - 10.1016/j.lana.2026.101621 UR - https://doi.org/10.1016/j.lana.2026.101621 ER -
APA
Curado, D. D. S. P., Santos, M., Palacios, A., Zimmermann, I. R., & Silva, E. N. D. (2026). Affordability of new drugs in the Brazilian public health system: a 13-year monitoring analysis of reimbursement decisions based on health technology assessments (2012–2024). The Lancet Regional Health - Americas. https://doi.org/10.1016/j.lana.2026.101621
Source records
- crossref · retrieved 2026-09-26T02:00:21.111Z